Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ShionogiTSE:4507 +0.26%92 EV-to-FCF is 14.39 as of Jul. 25, 2026, which is 7% below its 10-year median of 15.43. GuruFocus rates TSE:4507 with a GF Score™ of 92/100 and a GF Value™ of 円3,005.77 (Fairly Valued). The stock has 2 warning signs investors should review. Among 568 Drug Manufacturers companies, Shionogi ranks better than 63.73% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shionogi's Enterprise Value is 円2,093,198 Mil.
Shionogi's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円145,469 Mil. Therefore, Shionogi's EV-to-FCF for today is 14.39.
The historical rank and industry rank for Shionogi's EV-to-FCF or its related term are showing as below:
TSE:4507'
s EV-to-FCF Range Over the Past 10 Years
Min: 8.06 Med: 15.43 Max: 57.79
Current: 14.39
During the past 13 years, the highest EV-to-FCF of Shionogi was 57.79. The lowest was 8.06. And the median was 15.43.
TSE:4507's EV-to-FCF is ranked better than 63.73% of 568
companies
in the Drug Manufacturers industry
Industry Median: 21.015
vs TSE:4507: 14.39
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shionogi's share price for today is 円2855.50.
Shionogi's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円241.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shionogi EV-to-FCF Related Terms
Shionogi EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Shionogi's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shionogi EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shionogi's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shionogi's EV-to-FCF falls into.
Shionogi's current Enterprise Value is 円2,093,198 Mil.
Shionogi's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円145,469 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shionogi (TSE:4507) has a EV-to-FCF of 14.39 as of Jul. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shionogi and its competitors. This is near median its historical median of 15.43. Over the past decade, Shionogi's EV-to-FCF has ranged from 8.06 to 57.79. According to the industry distribution chart, Shionogi ranks #206 out of 568 companies in the Drug Manufacturers industry, placing it in the top 36.3%.
Is Shionogi's EV-to-FCF too high?
Shionogi's current EV-to-FCF of 14.39 is near median its 10-year median of 15.43. Over the past 10 years, this metric has ranged from a low of 8.06 to a high of 57.79. The Drug Manufacturers industry median EV-to-FCF is 21.02. Shionogi's value of 14.39 is 31.5% below this industry median. Based on the distribution chart, Shionogi ranks #206 out of 568 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shionogi has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shionogi's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shionogi ranks #206 out of 568 companies for EV-to-FCF. This puts Shionogi in the upper half of its industry. The industry median EV-to-FCF is 21.02. Shionogi's value of 14.39 is 31.5% below this benchmark. Historically, Shionogi's own EV-to-FCF has ranged from 8.06 to 57.79 over the past decade. While the company's 10-year median is 15.43 vs. the industry median of 21.02, Shionogi has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.02, based on 568 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shionogi's current EV-to-FCF of 14.39 is 31.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shionogi and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shionogi's current EV-to-FCF is 14.39, which is near median its own 10-year median of 15.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shionogi stock overvalued right now?
Based on GuruFocus' analysis, Shionogi (TSE:4507) is currently considered Fairly Valued. The stock's GF Value™ is 円3,005.77, compared to a current price of 円2,855.50 — trading 5% below its estimated fair value. The current EV-to-FCF is 14.39, which is near median its 10-year median of 15.43 and 31.5% below the Drug Manufacturers industry median of 21.02. Shionogi's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shionogi (TSE:4507), the current EV-to-FCF is 14.39 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shionogi (TSE:4507) Overvalued in 2026?
Based on GuruFocus' analysis, Shionogi stock appears to be undervalued.
The current stock price of 円2,855.50 is trading 5% below its estimated GF Value™ of 円3,005.77.
GuruFocus considers Shionogi to be Fairly Valued.
Key valuation signals for TSE:4507:
EV-to-FCF: 14.39 (near median its 10-year median of 15.43)
GF Value™: 円3,005.77 vs. price of 円2,855.50 (5% below fair value)
Industry Position: 31.5% below the Drug Manufacturers median (#206 of 568)
No single metric tells the full story. See the TSE:4507 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. The company engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late-stage drug discovery through commercial production. It provides products and services in Japan, Europe, North America, and other regions.
92GF Score
Get the complete analysis for TSE:4507
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4507 has been successfully added to your 
